Aura Biosciences Inc expected to post a loss of 41 cents a share - Earnings Preview

Aura Biosciences

01/03/2024 22:41

* Aura Biosciences Inc  AURA.OQ   AURA.O  is expected
to show no
change in quarterly revenue when it reports  results on March 4
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Aura Biosciences Inc is
for a
loss of 41 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aura
Biosciences
Inc is $20.00​, above​ its last closing price of $9.24. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.53       -0.52      -0.48     Beat    7.8
 Jun. 30 2023  -0.49       -0.49      -0.48     Beat    2
 Mar. 31 2023  -0.53       -0.54      -0.46     Beat    14.9​
 Dec. 31 2022  -0.47       -0.52      -0.55     Missed  -5.3
 ​​Sep.        -0.51       -0.51      -0.54     Missed  -6.7
 30 2022                                                
 Jun. 30 2022  -0.46       -0.46      -0.46     Met     0.9​
 Mar. 31 2022  -0.44       -0.44      -0.44     Met     -0.6
 Dec. 31 2021  -0.39       -0.39      -2.51     Missed  -538.1
 This summary was machine generated March 1 at 22:41 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)